Llwytho...
New Verse for a Familiar Song: Small Molecule Inhibitors for MET exon 14 Skipping Non‐Small Cell Lung Cancer
MET exon 14 skipping alterations (METex14) represent one of the newest discovered driver oncogene alterations for non‐small cell lung cancer (NSCLC), which serve to define a distinct elderly patient population. New challenges in detection and treatment have emerged. In the last 15 years, the success...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Oncologist |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley & Sons, Inc.
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7543381/ https://ncbi.nlm.nih.gov/pubmed/33400286 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0760 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|